These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 378348)

  • 1. Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy: a study of Cancer and Leukemia Groupe B.
    Falkson G; Falkson HC; Glidewell O; Weinberg V; Leone L; Holland JF
    Cancer; 1979 Jun; 43(6):2215-22. PubMed ID: 378348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
    Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL
    Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized evaluation of combination chemotherapy vs. observation alone following response or stabilization after oophorectomy for metastatic breast cancer in premenopausal women.
    Rossof AH; Gelman R; Creech RH
    Am J Clin Oncol; 1982 Jun; 5(3):253-9. PubMed ID: 7044099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenalectomy-oophorectomy and combined chemotherapy for carcinoma of the breast with metastases.
    Oberfield RA; Cady B; Pazianos AG; Salzman FA
    Surg Gynecol Obstet; 1979 Jun; 148(6):881-6. PubMed ID: 109935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
    Britell JC; Ahmann DL; Bisel HF; Frytak S; Ingle JN; Rubin J; O'Fallon JR
    Cancer Clin Trials; 1979; 2(4):345-50. PubMed ID: 394870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy of breast cancer.
    Cooper RG; Holland JF; Glidewell O
    Cancer; 1979 Sep; 44(3):793-8. PubMed ID: 476594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete remissions in metastatic breast cancer treated with combination drug therapy.
    Legha SS; Buzdar AU; Smith TL; Hortobagyi GN; Swenerton KD; Blumenschein GR; Gehan EA; Bodey GP; Freireich EJ
    Ann Intern Med; 1979 Dec; 91(6):847-52. PubMed ID: 517883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
    Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
    Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy.
    Ahmann DL; O'Connell MJ; Hahn RG; Bisel HF; Lee RA; Edmonson JH
    N Engl J Med; 1977 Aug; 297(7):356-60. PubMed ID: 876327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
    Cancer; 1979 Nov; 44(5):1955-62. PubMed ID: 387212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer.
    Yap HY; Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Krutchik AN; Benjamin RS; Gutterman JU; Bodey GP
    J Surg Oncol; 1979 Dec; 12(4):333-41. PubMed ID: 392197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of alternating cytoreductive and cycle-active combination chemotherapy for metastatic breast cancer.
    Vogel CL; Love NH; East DR; Moore MR; Smalley RV
    Cancer Treat Rep; 1979; 63(11-12):2077-9. PubMed ID: 526940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer.
    Ludwig Breast Cancer Study Group
    J Clin Oncol; 1985 Aug; 3(8):1059-67. PubMed ID: 2862223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
    Aisner J; Cirrincione C; Perloff M; Perry M; Budman D; Abrams J; Panasci L; Muss H; Citron M; Holland J
    J Clin Oncol; 1995 Jun; 13(6):1443-52. PubMed ID: 7751891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
    De Lena M; Brambilla C; Morabito A; Bonadonna G
    Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of treatment sequence in advanced and metastatic carcinoma of the breast.
    Awrich AE; Peetz ME; Moseley HS; Keenan E; Davenport CE; Fletcher WS
    J Surg Oncol; 1982 Sep; 21(1):9-17. PubMed ID: 7109642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy of metastatic breast cancer: a randomized trial comparing the use of adriamycin to that of Vinblastine.
    Bezwoda WR; de Moor NG; Derman D; Lange M; Saner R; Dando R
    Cancer; 1979 Aug; 44(2):392-7. PubMed ID: 383254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.
    Blumenschein GR; Hortobagyi GN; Richman SP; Gutterman JU; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Hersh EM
    Cancer; 1980 Feb; 45(4):742-9. PubMed ID: 6986970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.